The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-(3-acrylamidophenylsulfonyl)piperidin-4-yl)-4-(2,4,6-trichlorobenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate ID: ALA4474689
PubChem CID: 155537280
Max Phase: Preclinical
Molecular Formula: C27H24Cl3F3N6O7S
Molecular Weight: 625.92
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cc(Cl)cc3Cl)CC2)c1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C25H23Cl3N6O5S.C2HF3O2/c1-2-21(35)30-16-4-3-5-17(12-16)40(38,39)34-8-6-15(7-9-34)31-25(37)23-20(13-29-33-23)32-24(36)22-18(27)10-14(26)11-19(22)28;3-2(4,5)1(6)7/h2-5,10-13,15H,1,6-9H2,(H,29,33)(H,30,35)(H,31,37)(H,32,36);(H,6,7)
Standard InChI Key: YNQUOCFORHXVGP-UHFFFAOYSA-N
Molfile:
RDKit 2D
47 49 0 0 0 0 0 0 0 0999 V2000
40.2243 -14.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9320 -14.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5166 -14.2700 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.2243 -15.4958 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
39.5144 -15.0831 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
41.6397 -14.6786 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.9320 -13.4528 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.5136 -16.3603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.5177 -15.5431 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.8079 -15.9482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6228 -12.7119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4400 -12.7119 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2142 -12.0042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2142 -13.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3979 -13.4168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9894 -14.1237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3981 -14.8324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2195 -14.8298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6243 -14.1223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0744 -12.7119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8486 -12.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6658 -12.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9163 -11.2262 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.2538 -10.7476 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5940 -11.2298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8916 -12.7119 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6658 -13.4196 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.3002 -13.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8905 -14.1253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2956 -14.8309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1131 -14.8351 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.5239 -14.1275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1172 -13.4158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3362 -15.5474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7391 -16.2595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5555 -16.2629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9676 -15.5562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5573 -14.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7422 -14.8447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9611 -16.9724 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.7782 -16.9759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1838 -17.6853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1899 -16.2699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.0010 -17.6888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9907 -12.7083 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
32.4415 -14.1188 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.9904 -15.5406 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 1 0
1 5 1 0
2 6 1 0
2 7 2 0
9 8 2 0
10 9 2 0
11 12 1 0
11 13 2 0
11 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 21 1 0
22 20 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 21 2 0
20 26 1 0
20 27 2 0
26 28 1 0
28 29 1 0
28 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
31 9 1 0
9 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 34 1 0
36 40 1 0
40 41 1 0
41 42 1 0
41 43 2 0
42 44 2 0
15 45 1 0
19 46 1 0
17 47 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 625.92Molecular Weight (Monoisotopic): 624.0516AlogP: 4.33#Rotatable Bonds: 8Polar Surface Area: 153.36Molecular Species: NEUTRALHBA: 6HBD: 4#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.75CX Basic pKa: 0.01CX LogP: 4.15CX LogD: 4.15Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.27Np Likeness Score: -1.80
References 1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010 ] [10.1016/j.bmcl.2019.05.024 ]